Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Cancer Research

• Publication date

  1995-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 7743520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of proliferation and antigen expression of a cloned human glioblastoma by interleukin-4 alone and in combination with tumor necrosis factor-alpha and/or interferon-gamma.

  1993cited by this paper
• Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo.

  1993cited by this paper
• Inhibition of colon and breast carcinoma cell growth by interleukin-4.

  1992cited by this paper
• Antiproliferative effects of interleukin-4 on freshly isolated non-Hodgkin malignant B-lymphoma cells.

  1992cited by this paper
• An eosinophil-dependent mechanism for the antitumor effect of interleukin-4.

  1992cited by this paper
• Lack of effects of recombinant human interleukin-4 onin vitro colony formation of freshly explanted human tumor cells

  1992cited by this paper
• Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene.

  1992cited by this paper
• Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas.

  1991cited by this paper
• Human tumour-associated NK cells secrete increased amounts of interferon-gamma and interleukin-4.

  1991cited by this paper
• Interleukin 4 Alone and with γ-Interferon or α-Tumor Necrosis Factor Inhibits Cell Growth and Modulates Cell Surface Antigens on Human Renal Cell Carcinomas

  1991cited by this paper
• Interleukin-4 is a potent mitogen for capillary endothelium.

  1991cited by this paper
• Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

  1991cited by this paper
• Interleukin-4: a prototypic immunoregulatory lymphokine.

  1991cited by this paper
• Interleukin 4 receptor expression on human lung tumors and normal lung.

  1991cited by this paper
• IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production.

  1990cited by this paper
• Immunoglobulin isotype production by cycling human B lymphocytes in response to recombinant cytokines and anti-IgM.

  1990cited by this paper
• Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy?

  1989cited by this paper
• Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4.

  1988cited by this paper
• Characterization of the human B cell stimulatory factor 1 receptor

  1987cited by this paper
• B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes

  1987cited by this paper
• Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor

  1987cited by this paper
• Species-specificity of T cell stimulating activities of IL 2 and BSF-1 (IL 4): comparison of normal and recombinant, mouse and human IL 2 and BSF-1 (IL 4).

  1987cited by this paper
• B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.

  1987cited by this paper
• B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells.

  1987cited by this paper
• B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells.

  1986cited by this paper
• Molecular structure of human lymphocyte receptor for immunoglobulin E

  1986cited by this paper
• Molecular structure of human lymphocyte receptor for immunoglobulin E.

  1986cited by this paper
• Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1

  1985cited by this paper
• B-cell stimulatory factor 1 activates resting B cells.

  1985cited by this paper
• Cytotoxicity of the alkyl-linked lipoidal amine 4-aminomethyl-1-[2,3-(di-n-decyloxy)-n-propyl]-4-phenylpiperidine (CP-46,665) in cells from human tumors and leukemias.

  1985cited by this paper
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

  1984cited by this paper
• Identification of a T cell-derived b cell growth factor distinct from interleukin 2

  1982cited by this paper
• Tumor stem cell cloning in agar-containing capillaries

  1981cited by this paper

• Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer

  2021cites this paper
• Characterization and Therapeutic Manipulation of Glioblastoma-Associated Microglia, Macrophages, and Cytokines to Improve Prognosis

  2020cites this paper
• The Expression Levels of IL-4/IL-13/STAT6 Signaling Pathway Genes and SOCS3 Could Help to Differentiate the Histopathological Subtypes of Non-Small Cell Lung Carcinoma

  2018cites this paper
• Investigating the Role of miRNA-34 family in human thyroid cancer

  2017cites this paper
• Combination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition, immune system modulation and induction of p53 independent apoptosis

  2017cites this paper
• Does vitamin D mediate inhibition of epithelial ovarian cancer by modulating cytokines?

  2015cites this paper
• Low-grade inflammation, immune capacity, and cancer

  2014cites this paper
• Induction of Interferon-Stimulated Genes on the IL-4 Response Axis by Epstein-Barr Virus Infected Human B Cells; Relevance to Cellular Transformation

  2013cites this paper
• IL-4 in the Brain: A Cytokine To Remember

  2012cites this paper
• IL‐4 induces proliferation in prostate cancer PC3 cells under nutrient‐depletion stress through the activation of the JNK‐pathway and survivin up‐regulation

  2012cites this paper
• macrophages to promote cancer growth and invasion IL-4 induces cathepsin protease activity in tumor-associated

  2011cites this paper
• IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion.

  2010cites this paper
• Tumor Angiogenesis: Insights and Innovations

  2010cites this paper
• Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience.

  2009cites this paper
• SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer.

  2009cites this paper
• STAT6 Mediates Apoptosis of Human Coronary Arterial Endothelial Cells by Interleukin-13

  2008cites this paper
• PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling.

  2008cites this paper
• PTP 1 B is a negative regulator of interleukin 4 – induced STAT 6 signaling

  2008cites this paper
• Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51

  2007cites this paper
• Interleukin-4 cytotoxin therapy synergizes with gemcitabine in a mouse model of pancreatic ductal adenocarcinoma.

  2007cites this paper
• T-Cell Protein Tyrosine Phosphatase, Distinctively Expressed in Activated-B-Cell-Like Diffuse Large B-Cell Lymphomas, Is the Nuclear Phosphatase of STAT6

  2007influential citation
• Transfection of HT-29 and Hep-2 with IL-4R cDNA Increases the Sensitivity of the Cells Towards IL-4

  2006cites this paper
• Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors

  2006cites this paper
• Expression and targeting of interleukin-4 receptor for primary and advanced ovarian cancer therapy.

  2005cites this paper
• Review Gene therapy of malignant glioma: Recent advances in experimental and clinical studies

  2005cites this paper
• Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.

  2005cites this paper
• A clinical phase I/II trial of rhIL-4 applied topically in patients with oral squamous cell carcinomas to assess safety and therapeutic activity.

  2005cites this paper
• Influence of keratinocyte growth factor on clonal growth of epithelial tumor cells, lymphoma and leukemia cells and on sensitivity of tumor cells towards 5-fluorouracil in vitro.

  2004cites this paper
• Phase I trial of continuous infusion recombinant human interleukin-4 in patients with cancer

  2004cites this paper
• DUB-3, a Cytokine-inducible Deubiquitinating Enzyme That Blocks Proliferation*

  2004cites this paper
• Identification of the Interleukin 4 Receptor (cid:1) Gene as a Direct Target for p73

  2003cites this paper
• Current and future strategies for the treatment of malignant brain tumors.

  2003cites this paper
• Identification of the interleukin 4 receptor alpha gene as a direct target for p73.

  2003cites this paper
• Prevention of Brain Metastasis Formation by Local Expression of Interleukin-4 or Hemagglutinin Antigen

  2003cites this paper
• CHAPTER 10 – Interleukin-4

  2003cites this paper
• Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.

  2003cites this paper
• Phase II Trial of Recombinant Human Interleukin-4 in Patients With Advanced Renal Cell Carcinoma: A Southwest Oncology Group Study

  2002cites this paper
• Mechanisms of normal and tumor-derived angiogenesis.

  2002cites this paper
• STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells.

  2002cites this paper
• Cytokines and Immune Response in the Tumor Microenvironment

  2001cites this paper
• Essential for Protective Immunity T Cells by Interleukin-4-transfected 9 L Gliosarcoma Is + Cytokine Gene Therapy of Gliomas : Induction of Reactive CD 4 Updated Version

  2000cites this paper
• Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.

  2000cites this paper
• Interleukin-4 and breast cancer

  2000cites this paper
• Characterization of a novel negative regulatory element in the human interleukin 4 promoter

  2000cites this paper
• Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene.

  1999cites this paper
• Retrovirus-mediated IL-4 gene therapy in spontaneous adenocarcinomas from MMTV-neu transgenic mice

  1999cites this paper
• Inhibition of Angiogenesis by Interleukin 4

  1998cites this paper
• Phase II Trial of Recombinant Human Interleukin‐4 in Patients with Disseminated Malignant Melanoma: A Southwest Oncology Group Study

  1998cites this paper
• Head and neck cancers, but not benign lesions, express interleukin-4 receptors in situ.

  1998cites this paper
• Interleukins 4 and 13 upregulate expression of cd44 in human colonic epithelial cell lines.

  1998cites this paper
• IL-4 gene transfer for the treatment of experimental gliomas.

  1998cites this paper
• Interleukin-4 and interleukin-13: their similarities and discrepancies.

  1998cites this paper
• Lymphokines and Cytokines

  1998cites this paper
• Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.

  1998cites this paper
• Gene therapy of malignant glioma: recent advances in experimental and clinical studies.

  1998cites this paper
• The CDK inhibitor, p27Kip1, is required for IL-4 regulation of astrocyte proliferation.

  1997cites this paper
• Limited Efficacy of the HSV-TK/GCV System for Gene Therapy of Malignant Gliomas and Perspectives for the Combined Transduction of the Interleukin-4 Gene

  1997cites this paper
• IL-4 and TNF-α induce changes in integrin expression and adhesive properties and decrease the lung-colonizing potential of HT-29 colon carcinoma cells

  1996cites this paper
• Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13.

  1996cites this paper
• A cytokine profile of normal and malignant ovary.

  1996cites this paper
• An antiproliferative bioassay for interleukin-4.

  1996cites this paper
• The cytokine microenvironment of human colon carcinoma: Lymphocyte expression of tumor necrosis factor‐α and interleukin‐4 predicts improved survival

  1996cites this paper
• IL-4 and TNF-alpha induce changes in integrin expression and adhesive properties and decrease the lung-colonizing potential of HT-29 colon carcinoma cells.

  1996cites this paper
• Regulation of 15-lipoxygenase expression in lung epithelial cells by interleukin-4.

  1996cites this paper